201 related articles for article (PubMed ID: 19359041)
1. Defective B cell ontogeny and humoral immune response in mice prematurely expressing human complement receptor 2 (CR2, CD21) is similar to that seen in aging wild type mice.
Twohig JP; Pappworth IY; Sivasankar B; Kulik L; Bull M; Holers VM; Wang EC; Marchbank KJ
Mol Immunol; 2009 Jun; 46(10):2002-13. PubMed ID: 19359041
[TBL] [Abstract][Full Text] [Related]
2. Human complement receptor type 2 (CR2/CD21) transgenic mice provide an in vivo model to study immunoregulatory effects of receptor antagonists.
Kulik L; Chen K; Huber BT; Holers VM
Mol Immunol; 2011 Mar; 48(6-7):883-94. PubMed ID: 21269698
[TBL] [Abstract][Full Text] [Related]
3. Expression of human complement receptor 2 (CR2, CD21) in Cr2-/- mice restores humoral immune function.
Marchbank KJ; Watson CC; Ritsema DF; Holers VM
J Immunol; 2000 Sep; 165(5):2354-61. PubMed ID: 10946257
[TBL] [Abstract][Full Text] [Related]
4. B cells from mice prematurely expressing human complement receptor type 2 are unresponsive to T-dependent antigens.
Birrell L; Kulik L; Morgan BP; Holers VM; Marchbank KJ
J Immunol; 2005 Jun; 174(11):6974-82. PubMed ID: 15905540
[TBL] [Abstract][Full Text] [Related]
5. Defective B cell ontogeny and immune response in human complement receptor 2 (CR2, CD21) transgenic mice is partially recovered in the absence of C3.
Twohig J; Kulik L; Haluszczak C; Reuter J; Rossbach A; Bull M; Holers VM; Marchbank KJ
Mol Immunol; 2007 Jul; 44(13):3434-44. PubMed ID: 17379312
[TBL] [Abstract][Full Text] [Related]
6. Mice expressing human CR1/CD35 have an enhanced humoral immune response to T-dependent antigens but fail to correct the effect of premature human CR2 expression.
Pappworth IY; Hayes C; Dimmick J; Morgan BP; Holers VM; Marchbank KJ
Immunobiology; 2012 Feb; 217(2):147-57. PubMed ID: 21783272
[TBL] [Abstract][Full Text] [Related]
7. Increased B cell deletion and significantly reduced auto-antibody titre due to premature expression of human complement receptor 2 (CR2, CD21).
Pappworth IY; Kulik L; Haluszczak C; Reuter JW; Holers VM; Marchbank KJ
Mol Immunol; 2009 Mar; 46(6):1042-9. PubMed ID: 19187965
[TBL] [Abstract][Full Text] [Related]
8. Intrinsic B cell hypo-responsiveness in mice prematurely expressing human CR2/CD21 during B cell development.
Kulik L; Marchbank KJ; Lyubchenko T; Kuhn KA; Liubchenko GA; Haluszczak C; Gipson MG; Boackle SA; Holers VM
Eur J Immunol; 2007 Mar; 37(3):623-33. PubMed ID: 17301948
[TBL] [Abstract][Full Text] [Related]
9. Expression of human complement receptor type 2 (CD21) in mice during early B cell development results in a reduction in mature B cells and hypogammaglobulinemia.
Marchbank KJ; Kulik L; Gipson MG; Morgan BP; Holers VM
J Immunol; 2002 Oct; 169(7):3526-35. PubMed ID: 12244142
[TBL] [Abstract][Full Text] [Related]
10. Mouse complement receptors type 1 (CR1;CD35) and type 2 (CR2;CD21): expression on normal B cell subpopulations and decreased levels during the development of autoimmunity in MRL/lpr mice.
Takahashi K; Kozono Y; Waldschmidt TJ; Berthiaume D; Quigg RJ; Baron A; Holers VM
J Immunol; 1997 Aug; 159(3):1557-69. PubMed ID: 9233655
[TBL] [Abstract][Full Text] [Related]
11. A new mouse anti-mouse complement receptor type 2 and 1 (CR2/CR1) monoclonal antibody as a tool to study receptor involvement in chronic models of immune responses and disease.
Kulik L; Hewitt FB; Willis VC; Rodriguez R; Tomlinson S; Holers VM
Mol Immunol; 2015 Feb; 63(2):479-88. PubMed ID: 25457881
[TBL] [Abstract][Full Text] [Related]
12. Dependence of germinal center B cells on expression of CD21/CD35 for survival.
Fischer MB; Goerg S; Shen L; Prodeus AP; Goodnow CC; Kelsoe G; Carroll MC
Science; 1998 Apr; 280(5363):582-5. PubMed ID: 9554848
[TBL] [Abstract][Full Text] [Related]
13. Antibody response to a T-dependent antigen requires B cell expression of complement receptors.
Croix DA; Ahearn JM; Rosengard AM; Han S; Kelsoe G; Ma M; Carroll MC
J Exp Med; 1996 Apr; 183(4):1857-64. PubMed ID: 8666942
[TBL] [Abstract][Full Text] [Related]
14. Impaired affinity maturation in Cr2-/- mice is rescued by adjuvants without improvement in germinal center development.
Wu X; Jiang N; Fang YF; Xu C; Mao D; Singh J; Fu YX; Molina H
J Immunol; 2000 Sep; 165(6):3119-27. PubMed ID: 10975825
[TBL] [Abstract][Full Text] [Related]
15. Complement component C3d-antigen complexes can either augment or inhibit B lymphocyte activation and humoral immunity in mice depending on the degree of CD21/CD19 complex engagement.
Lee Y; Haas KM; Gor DO; Ding X; Karp DR; Greenspan NS; Poe JC; Tedder TF
J Immunol; 2005 Dec; 175(12):8011-23. PubMed ID: 16339538
[TBL] [Abstract][Full Text] [Related]
16. Effect of short-term cocaine administration on the immune system of young and old C57BL/6 female mice.
Colombo LL; López MC; Chen GJ; Watson RR
Immunopharmacol Immunotoxicol; 1999 Nov; 21(4):755-69. PubMed ID: 10584210
[TBL] [Abstract][Full Text] [Related]
17. Cutting edge: Complement (C3d)-linked antigens break B cell anergy.
Lyubchenko T; Dal Porto JM; Holers VM; Cambier JC
J Immunol; 2007 Sep; 179(5):2695-9. PubMed ID: 17709481
[TBL] [Abstract][Full Text] [Related]
18. Markedly impaired humoral immune response in mice deficient in complement receptors 1 and 2.
Molina H; Holers VM; Li B; Fung Y; Mariathasan S; Goellner J; Strauss-Schoenberger J; Karr RW; Chaplin DD
Proc Natl Acad Sci U S A; 1996 Apr; 93(8):3357-61. PubMed ID: 8622941
[TBL] [Abstract][Full Text] [Related]
19. Role of complement receptor type 2 and endogenous complement in the humoral immune response to conjugates of complement C3d and pneumococcal serotype 14 capsular polysaccharide.
Mitsuyoshi JK; Hu Y; Test ST
Infect Immun; 2005 Nov; 73(11):7311-6. PubMed ID: 16239528
[TBL] [Abstract][Full Text] [Related]
20. Optimal germinal center B cell activation and T-dependent antibody responses require expression of the mouse complement receptor Cr1.
Donius LR; Handy JM; Weis JJ; Weis JH
J Immunol; 2013 Jul; 191(1):434-47. PubMed ID: 23733878
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]